Gene · 7439
Papers1,518
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,518
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cytosolic domain regulates the calcium sensitivity and surface expression of BEST1 channels in the HEK293 cells. | BMB Rep | 2023 | 36593105 | PubTator, text mining | PubMed |
| Visual function restoration in a mouse model of Leber congenital amaurosis via therapeutic base editing. | Mol Ther Nucleic Acids | 2023 | 36589710 | PubTator, text mining | PubMed |
| Choroidal Neovascularization Is Common in Best Vitelliform Macular Dystrophy and Plays a Role in Vitelliform Lesion Evolution. | Ophthalmol Retina | 2023 | 36528270 | PubTator, text mining | PubMed |
| Photoreceptor function and structure in retinal degenerations caused by biallelic BEST1 mutations. | Vision Res | 2023 | 36450205 | PubTator, text mining | PubMed |
| BEST1 novel mutation causes Bestrophinopathies in six families with distinct phenotypic diversity. | Mol Genet Genomic Med | 2023 | 36378562 | PubTator, text mining | PubMed |
| Distinct Phenotypic Consequences of Pathogenic Mutants Associated with Late-Onset Retinal Degeneration. | Am J Pathol | 2023 | 36328299 | PubTator, text mining | PubMed |
| Identifying Novel Genes and Variants in Immune and Coagulation Pathways Associated with Macular Degeneration. | Ophthalmol Sci | 2023 | 36275200 | PubTator, text mining | PubMed |
| Multisystem physiological perspective of human frailty and its modulation by physical activity. | Physiol Rev | 2023 | 36239451 | PubTator, text mining | PubMed |
| Retinal organoids provide unique insights into molecular signatures of inherited retinal disease throughout retinogenesis. | J Anat | 2023 | 36177499 | PubTator, text mining | PubMed |
| Dissection of mendelian predisposition and complex genetic architecture of craniovertebral junction malformation. | Hum Genet | 2023 | 36098810 | PubTator, text mining | PubMed |
| Autosomal recessive bestrophinopathy associated with compound heterozygous variants in the BEST1 gene. | Ophthalmic Genet | 2023 | 36062537 | PubTator, text mining | PubMed |
| Genetic treatment for autosomal dominant inherited retinal dystrophies: approaches, challenges and targeted genotypes. | Br J Ophthalmol | 2023 | 36038193 | PubTator, text mining | PubMed |
| Aß Pathology and Neuron-Glia Interactions: A Synaptocentric View. | Neurochem Res | 2023 | 35976488 | PubTator, text mining | PubMed |
| Clinical-genetic findings in a group of subjects with macular dystrophies due to mutations in rare inherited retinopathy genes. | Graefes Arch Clin Exp Ophthalmol | 2023 | 35947183 | PubTator, text mining | PubMed |
| Twelve-year follow up of a case of autosomal recessive bestrophinopathy with transient resolution of retinal edema in one eye. | Eur J Ophthalmol | 2023 | 34989278 | PubTator, text mining | PubMed |
| Intravitreal bevacizumab treatment for exudative choroidal neovascularisation in best vitelliform macular dystrophy. | Eur J Ophthalmol | 2023 | 34779297 | PubTator, text mining | PubMed |
| ADULT-ONSET BEST1 -VITELLIFORM DYSTROPHY ASSOCIATED WITH ANGIOID STREAK-LIKE CHANGES IN TWO SIBLINGS. | Retin Cases Brief Rep | 2023 | 34001763 | PubTator, text mining | PubMed |
| Coronavirus Disease 2019-induced Acute Exudative Polymorphous Vitelliform Maculopathy. | Middle East Afr J Ophthalmol | 2022 | 38162565 | PubTator, text mining | PubMed |
| Autosomal Recessive Bestrophinopathy Presenting With a Macular Hole Retinal Detachment. | J Vitreoretin Dis | 2022 | 37007926 | PubTator, text mining | PubMed |
| Autosomal Dominant Vitreoretinochoroidopathy With a Novel BEST1 Mutation and a Review of Reported Mutations. | Cureus | 2022 | 36712704 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7439/papers?page=12